From: HIV diagnosis period influences ART initiation: findings from a prospective cohort study in China
 | All | Diagnosed before implementing the new strategy | Diagnosed after implementing the new strategy | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HRu (95% CI) | P | HRa (95% CI) | P | HRu (95% CI) | P | HRa (95% CI) | P | HRu (95% CI) | P | HRa (95% CI) | P | |
Perceived severity | 1.32 (1.13, 1.54) | 0.001 | 1.17 (0.99, 1.38) | 0.060 | 1.43 (1.10, 1.86) | 0.007 | 1.54 (1.17, 2.02) | 0.002 | 1.03 (0.83, 1.27) | 0.797 | 0.99 (0.80, 1.23) | 0.957 |
Perceived susceptibility | 1.18 (1.02, 1.37) | 0.029 | 1.09 (0.94, 1.27) | 0.251 | 1.24 (0.96, 1.61) | 0.096 | 1.34 (1.02, 1.75) | 0.034 | 1.03 (0.86, 1.24) | 0.746 | 1.00 (0.84, 1.19) | 0.990 |
Perceived benefits | 1.28 (1.08, 1.52) | 0.005 | 1.15 (0.97, 1.38) | 0.117 | 1.66 (1.23, 2.24) | 0.001 | 1.83 (1.34, 2.51) | < 0.001 | 0.95 (0.76, 1.19) | 0.647 | 0.92 (0.74, 1.15) | 0.459 |
Perceived barriers | 0.86 (0.74, 0.99) | 0.039 | 0.91 (0.79, 1.06) | 0.216 | 0.70 (0.53, 0.91) | 0.008 | 0.71 (0.55, 0.93) | 0.014 | 1.00 (0.84, 1.19) | 0.991 | 0.98 (0.83, 1.17) | 0.824 |
Self-efficacy | 1.38 (1.20, 1.60) | < 0.001 | 1.23 (1.06, 1.43) | 0.006 | 1.45 (1.15, 1.84) | 0.002 | 1.56 (1.23, 1.97) | < 0.001 | 1.11 (0.92, 1.35) | 0.272 | 1.06 (0.87, 1.29) | 0.576 |